Viewing Study NCT06881992


Ignite Creation Date: 2025-12-24 @ 3:21 PM
Ignite Modification Date: 2026-01-02 @ 1:08 PM
Study NCT ID: NCT06881992
Status: RECRUITING
Last Update Posted: 2025-10-21
First Post: 2025-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Sponsor: Rezolute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module